UNSPSC 85552530: Replacement of right upper eyelid with nonautologous tissue substitute, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right upper eyelid with nonautologous tissue substitute, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 08RNXKZ

UNSPSC 85552530 Replacement of right upper eyelid with nonautologous tissue substitute, external approach is a Commodity code that does not show material recent state and local procurement activity. The code nominally describes a specific ophthalmic surgical procedure, but the six recent opportunities posted under it involve independent medical evaluation services, surgical benefit carve-out programs for employee health plans, occupational medical surveillance, specialty emergency medical care for detained youth, pharmacy benefit management, and temporary ancillary health professional staffing — none of which align with eyelid reconstruction surgery or constitute procurement of that service. The mismatch signals either a broad UNSPSC tagging error across multiple jurisdictions or a systematic misclassification of health-services categories in the state and local procurement system.

No state and local government appears to be actively soliciting eyelid replacement procedures or related surgical supplies under this code. The opportunities span issuing bodies from Arizona (City of Phoenix Retirement Office), California (City of Long Beach and County of Santa Clara Health System), Washington (Washington State Department of Transportation), Texas (Harris County), and Florida (Collier County Board of County Commissioners), but none involve procurement of the service the code nominally describes. Unless the code is being used to tag a broader class of surgical or medical-device procurement not evident in the source material, this category shows no actionable buying signal for vendors engaged in ophthalmic procedures or tissue-substitute products.